Effect of chronic administration of recombinant bovine tumor necrosis factor to cattle.
Cachectin/tumor necrosis factor-alpha (TNF), a protein produced by macrophages upon stimulation, has been implicated as an important mediator of inflammatory processes and of clinical manifestations in chronic infectious diseases. In order to study further the potential role of TNF in infectious diseases, a homologous system was employed in which recombinant Escherichia coli (E. coli) derived bovine TNF (rBoTNF) was injected in cattle, either as a single bolus or in a repetitive treatment-regime. No clinical signs were observed, although changes occurred in hematologic and immunologic parameters when less than 0.5 mg of TNF/100 kg body weight was administered twice daily for 18 days. Prolonged treatment with 0.05-0.5 mg/100 kg induced histologic but no gross changes in the kidneys and liver. When doses were increased above 0.5 mg/100 kg, depression, anorexia, cachexia, and diarrhea appeared rapidly. Pathologic changes were apparent in various tissues including liver, kidneys, and lymphoid organs; body fat depots were depleted. Most of these changes appeared to be reversible; return to normal tissue-morphology occurred within 3 weeks of withdrawal of rBoTNF. The clinical and pathologic changes induced by prolonged rBoTNF administration resembled those observed in some chronic parasitic and viral infections of cattle in which macrophage-activation characteristically occur. Our finding may be relevant to the elucidation of the pathogenesis of these and other chronic infections.
Bielefeldt Ohmann
H
H
Department of Veterinary Pathology, Western College of Veterinary Medicine, Saskatoon, Saskatchewan, Canada.
Campos
M
M
Snider
M
M
Rapin
N
N
Beskorwayne
T
T
Popowych
Y
Y
Lawman
M J
MJ
Rossi
A
A
Babiuk
L A
LA
D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology*; D007583:Jejunum / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D007958:Leukocyte Count / Q000662:veterinary; D007962:Leukocytes / Q000187:drug effects; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008221:Lymphoid Tissue / Q000187:drug effects; D009000:Monocytes / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects; D010641:Phenotype; D011994:Recombinant Proteins / Q000633:toxicity; D013234:Stem Cells / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000633:toxicity*
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha